Table 3 Reasons for ART discontinuation by study period
Reason for discontinuation | Year of initial ART | |||
|---|---|---|---|---|
2011–2014 n (%) | 2015–Feb 2017 n (%) | Total n (%) | P | |
Intolerance/toxicity | 91 (47.2) | 67 (42.4) | 158 (45.0) | 0.056 |
Treatment simplification | 12 (6.2) | 22 (13.9) | 34 (9.7) | 0.086 |
Patient’s willingness | 16 (8.3) | 10 (6.3) | 26 (7.4) | 0.239 |
Poor compliance | 16 (8.3) | 9 (5.7) | 25 (7.1) | 0.162 |
Prevention of future toxicities | 6 (3.1) | 15 (9.5) | 21 (6.0) | 0.049 |
Virologic failure | 17 (8.8) | 2 (1.3) | 19 (5.4) | 0.001 |
Clinician’s preference | 6 (3.1) | 13 (8.2) | 19 (5.4) | 0.108 |
Others | 29 (15.0) | 20 (12.7) | 49 (14.0) | 0.199 |
Total | 193 (100) | 158 (100) | 351 (100) | |